Axogen (AXGN) Cash from Financing Activities (2010 - 2026)
Axogen (AXGN) posted Cash from Financing Activities of $4.2 million for Q2 2026, down 92.95% on a QoQ basis from $59.5 million in Q1 2026, and up 262.75% year-over-year from $1.2 million in Q2 2025.
Analysis
Axogen (AXGN) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Axogen has reported Cash from Financing Activities for 17 years, with the latest figure at $4.2 million in Q2 2026.
- On a quarterly basis, Cash from Financing Activities rose 262.75% year-over-year to $4.2 million in Q2 2026; TTM through Jun 2026 was $70.7 million, a 1290.71% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 358.47% from the prior year.
- Cash from Financing Activities was $4.2 million for Q2 2026 at Axogen, down from $59.5 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $59.5 million in Q1 2026, with the low at $5000.0 in Q3 2023.
- Average Cash from Financing Activities over 5 years is $4.5 million, with a median of $742000.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities sank 97.67% in 2023, then soared 11340.0% in 2024.
- Over 5 years, Cash from Financing Activities stood at $813000.0 in 2022, then plunged by 48.59% to $418000.0 in 2023, then jumped by 132.06% to $970000.0 in 2024, then surged by 370.72% to $4.6 million in 2025, then decreased by 8.08% to $4.2 million in 2026.
- The last three Cash from Financing Activities figures came in at $4.2 million (Q2 2026), $59.5 million (Q1 2026), and $4.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Axogen | 2.59 Bn | 2.48 Bn | 50.67 Mn | 4.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.20 Mn |
| Mar 31, 2026 | 59.51 Mn |
| Dec 31, 2025 | 4.57 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 970,000.00 |
| Sep 30, 2024 | 572,000.00 |
| Jun 30, 2024 | 544,000.00 |
| Mar 31, 2024 | 204,000.00 |
| Dec 31, 2023 | 418,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 898,000.00 |
| Mar 31, 2023 | 633,000.00 |
| Dec 31, 2022 | 813,000.00 |
| Sep 30, 2022 | 215,000.00 |
| Jun 30, 2022 | 671,000.00 |
| Mar 31, 2022 | 95,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 805,000.00 |